Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul 28;144(6):1629-1631.
doi: 10.1093/brain/awab168.

On the intersection between systemic infection, brain vascular dysfunction and dementia

Mikko T Huuskonen  1   2 , Kassandra Kisler  1   2 , Abhay P Sagare  1   2 , Berislav V Zlokovic  1   2
Affiliations
Comment

On the intersection between systemic infection, brain vascular dysfunction and dementia

Mikko T Huuskonen et al. Brain. .

Abstract

This scientific commentary refers to ‘Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer’s disease’ by Asby et al. (doi:10.1093/brain/awab094).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Common features of cerebrovascular dysfunction in vascular dementia and Alzheimer’s disease. Both vascular dementia (VaD) and Alzheimer’s disease (AD) share markers of cerebrovascular dysfunction and elevated cytokines that are further exacerbated by systemic infection (SI), as shown by Asby et al. Other factors can also influence or aggravate elevation of these markers.
See this image and copyright information in PMC

Comment on

References

    1. Sweeney MD, Sagare AP, Zlokovic BV.. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133–150. - PMC - PubMed
    1. Sweeney MD, Sagare AP, Pachicano M, et al.A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid. Alzheimers Dement. 2020;16(6):821–830. - PMC - PubMed
    1. Nation DA, Sweeney MD, Montagne A, et al.Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25(2):270–276. - PMC - PubMed
    1. Montagne A, Nation DA, Sagare AP, et al.APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71–76. - PMC - PubMed
    1. Kapasi A, DeCarli C, Schneider JA.. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017;134(2):171–186. - PMC - PubMed

Publication types